Clinical outcomes in stage III non-small cell lung cancer patients treated with durvalumab after sequential or concurrent platinum-based chemoradiotherapy – single institute experience
, , , , oraz
19 lis 2021
O artykule
Kategoria artykułu: Research Article
Data publikacji: 19 lis 2021
Zakres stron: 482 - 490
Otrzymano: 19 sie 2021
Przyjęty: 07 paź 2021
DOI: https://doi.org/10.2478/raon-2021-0044
Słowa kluczowe
© 2021 Martina Vrankar, Karmen Stanic, Stasa Jelercic, Eva Ciric, Ana Lina Vodusek, Jasna But-Hadzic, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Vrankar, Martina
Institute of Oncology Ljubljana, Department of RadiotherapyLjubljana, Slovenia
University of Ljubljana, Faculty of MedicineLjubljana, Slovenia
Stanic, Karmen
Institute of Oncology Ljubljana, Department of RadiotherapyLjubljana, Slovenia
University of Ljubljana, Faculty of MedicineLjubljana, Slovenia
Jelercic, Stasa
Institute of Oncology Ljubljana, Department of RadiotherapyLjubljana, Slovenia
Ciric, Eva
Institute of Oncology Ljubljana, Department of RadiotherapyLjubljana, Slovenia
Vodusek, Ana Lina
Institute of Oncology Ljubljana, Department of RadiotherapyLjubljana, Slovenia
But-Hadzic, Jasna
Institute of Oncology Ljubljana, Department of RadiotherapyLjubljana, Slovenia
University of Ljubljana, Faculty of MedicineLjubljana, Slovenia